CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-24 | Jackson Benjamin E.V.P., General Counsel | Grant or award | +18,879 | 107,029 | ||
| 2020-10-08 | Jackson Benjamin E.V.P., General Counsel | Grant or award | +29,784 | 88,150 | ||
| 2020-09-30 | Jackson Benjamin E.V.P., General Counsel | Returned to the company | −416 | $13.04 | $5K | 58,366 |
| 2020-09-26 | Jackson Benjamin E.V.P., General Counsel | Returned to the company | −2,935 | $12.44 | $37K | 58,782 |
| 2020-09-25 | Jackson Benjamin E.V.P., General Counsel | Returned to the company | −367 | $12.44 | $5K | 62,170 |
| 2020-09-25 | Jackson Benjamin E.V.P., General Counsel | Returned to the company | −453 | $12.44 | $6K | 61,717 |
| 2020-08-12 | Jackson Benjamin E.V.P., General Counsel | Grant or award | +6,541 | 62,537 |
Page 1 of 1 · 7 trades